Thymic Output and CD4 T-Cell Reconstitution in HIV-Infected Children on Early and Interrupted Antiretroviral Treatment: Evidence from the Children with HIV Early Antiretroviral Therapy Trial

Thymic Output and CD4 T-Cell Reconstitution in HIV-Infected Children on Early and Interrupted Antiretroviral Treatment: Evidence from the Children with HIV Early Antiretroviral Therapy Trial

<h4>Objectives</h4> <p>Early treatment of HIV-infected children and adults is important for optimal immune reconstitution. Infants’ immune systems are more plastic and dynamic than older children’s or adults’, and deserve particular attention. This study aimed to understand the re...

Полное описание

Библиографические подробности
Главные авторы:	Lewis, J, Payne, H, Walker, A, Otwombe, K, Gibb, D, Babiker, A, Panchia, R, Cotton, M, Violari, A, Klein, N, Callard, R
Формат:	Journal article
Опубликовано:	Frontiers Media 2017

Схожие документы

Prevalence and Risk Factors for Hepatic Steatosis in Children With Perinatal HIV on Early Antiretroviral Therapy Compared to HIV-Exposed Uninfected and HIV-Unexposed Children
по: Penelope C. Rose, и др.
Опубликовано: (2022-06-01)

Age and CD4 count at initiation of antiretroviral therapy in HIV-infected children: effects on long-term T-cell reconstitution.
по: Lewis, J, и др.
Опубликовано: (2012)

Early severe HIV disease precedes early antiretroviral therapy in infants: Are we too late?
по: Steve Innes, и др.
Опубликовано: (2014-01-01)

Relationship between changes in thymic emigrants and cell-associated HIV-1 DNA in HIV-1-infected children initiating antiretroviral therapy.
по: De Rossi, A, и др.
Опубликовано: (2005)

Cortical structural changes related to early antiretroviral therapy (ART) interruption in perinatally HIV-infected children at 5 years of age
по: Emmanuel C. Nwosu, и др.
Опубликовано: (2021-06-01)

Early ART-initiation and longer ART duration reduces HIV-1 proviral DNA levels in children from the CHER trial
по: Helen Payne, и др.
Опубликовано: (2021-09-01)

When to start antiretroviral therapy in infants and children
по: Mark F Cotton, и др.
Опубликовано: (2009-12-01)

When should children with HIV infection be started on antiretroviral therapy?
по: Steven B Welch, и др.
Опубликовано: (2008-03-01)

Predicting patterns of long-term CD4 reconstitution in HIV-infected children starting antiretroviral therapy in sub-Saharan Africa: a cohort-based modelling study.
по: Picat, M, и др.
Опубликовано: (2013)

A child with perinatal HIV infection and long-term sustained virological control following antiretroviral treatment cessation
по: Avy Violari, и др.
Опубликовано: (2019-01-01)

6 Epigenetic dysregulation of the major histocompatibility complex (MHC) region in HIV-infected children on early antiretroviral therapy
по: Stephanie Shiau, и др.
Опубликовано: (2017-07-01)

Antiretroviral therapy interruptions: impact on HIV treatment and transmission
по: Dubrocq G, и др.
Опубликовано: (2018-06-01)

Different profiles of immune reconstitution in children and adults with HIV-infection after highly active antiretroviral therapy
по: Leal Manuel, и др.
Опубликовано: (2006-07-01)

Virological remission after antiretroviral therapy interruption in female African HIV seroconverters
по: Gossez, M, и др.
Опубликовано: (2018)

Biphasic decay of cell-associated HIV-1 DNA in HIV-1-infected children on antiretroviral therapy.
по: De Rossi, A, и др.
Опубликовано: (2002)

The Benefits of Early Antiretroviral Therapy for HIV Infection: How Early is Early Enough?
по: Sulggi A. Lee, и др.
Опубликовано: (2016-09-01)

Cases inefficient antiretroviral therapy for HIV-1 in children
по: Yu. V. Ostankova, и др.
Опубликовано: (2017-06-01)

Pubertal development in HIV-infected African children on first-line antiretroviral therapy.
по: Szubert, A, и др.
Опубликовано: (2015)

Monitoring of highly active antiretroviral therapy in HIV infection.
по: Walker, A, и др.
Опубликовано: (2011)

Cardiac Effects of Antiretroviral-Naïve versus Antiretroviral-Exposed HIV Infection in Children.
по: Nikmah S Idris, и др.
Опубликовано: (2016-01-01)

Interrupting antiretroviral treatment in HIV cure research: scientific and ethical considerations
по: Samual A. Garner, и др.
Опубликовано: (2017-04-01)

IMPROVING ANTIRETROVIRAL THERAPY IN CHILDREN WITH HIV INFECTION
по: V. B. Denisenko, и др.
Опубликовано: (2018-07-01)

Antiretroviral therapy during pregnancy and early neonatal life: consequences for HIV-exposed, uninfected children
по: Patrícia El Beitune, и др.

Interruptions of antiretroviral therapy in children and adolescents with HIV infection in clinical practice: a retrospective cohort study in the USA
по: Natella Rakhmanina, и др.
Опубликовано: (2016-01-01)

Understanding early HIV-1 rebound dynamics following antiretroviral therapy interruption: The importance of effector cell expansion.
по: Tin Phan, и др.
Опубликовано: (2024-07-01)

Correction: Association of Diversity with Antiretroviral Treatment Outcomes among HIV-Infected African Children.
по: Iris Chen, и др.
Опубликовано: (2013-01-01)

Preventing antiretroviral treatment interruptions among HIV/AIDS patients in Africa.
по: Edward J Mills, и др.
Опубликовано: (2013-01-01)

Unwillingness of patients in Ghana to interrupt antiretroviral therapy for HIV cure research
по: Evelyn Y. Bonney, и др.
Опубликовано: (2021-03-01)

Pharmacokinetics of antiretroviral drug varies with formulation in the target population of children with HIV-1.
по: Kasirye, P, и др.
Опубликовано: (2012)

Antiretroviral choice and severe disease predict poorer neuropsychological outcomes in HIV+ children from Africa
по: Lee Fairlie, и др.
Опубликовано: (2022-08-01)

Excellent adherence to antiretrovirals in HIV+ Zambian children is compromised by disrupted routine, HIV nondisclosure, and paradoxical income effects
по: Haberer, J, и др.
Опубликовано: (2011)

Drug monitoring of antiretroviral drugs in children with perinatal HIV infection
по: A. Yu. Sambyalova, и др.
Опубликовано: (2024-07-01)

Early antiretroviral therapy reduces hiv dna following perinatal HIV infection
по: Foster, C, и др.
Опубликовано: (2017)

Anthropometric measurements and lipid profiles to detect early lipodystrophy in antiretroviral therapy experienced HIV-infected children in the CHAPAS-3 trial.
по: Musiime, V, и др.
Опубликовано: (2014)

When to start antiretroviral therapy in HIV-infected children
по: Tammy Meyers
Опубликовано: (2002-07-01)

Hepatotoxicity in HIV-infected children and adolescents on antiretroviral therapy
по: Ana Cecília Montes Gil, и др.

Adherence and effectiveness of antiretroviral therapy in HIV infected children
по: K S Sanjay, и др.
Опубликовано: (2016-01-01)

Evolution of antiretroviral phenotypic and genotypic drug resistance in antiretroviral-naive HIV-1-infected children treated with abacavir/lamivudine, zidovudine/lamivudine or abacavir/zidovudine, with or without nelfinavir (the PENTA 5 trial).
по: Gibb, D, и др.
Опубликовано: (2002)

Early Colorectal Responses to HIV-1 and Modulation by Antiretroviral Drugs
по: Carolina Herrera, и др.
Опубликовано: (2021-03-01)

Increased thymic output after initiation of antiretroviral therapy in human immunodeficiency virus type 1-infected children in the Paediatric European Network for Treatment of AIDS (PENTA) 5 Trial.
по: De Rossi, A, и др.
Опубликовано: (2002)